Traynor Capital Management’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$420K Buy
2025
Q2
$218K Buy
2025
Q1
$93.8K Buy
2024
Q4
$71.8K Buy
2024
Q3
$118K Hold
2024
Q2
$96.9K Buy
2024
Q1
$83K Hold
2023
Q4
$57.6K Hold
2023
Q3
$66.6K Buy